Methylphenidate hydrochloride and Irbesartan drug interactions - from FDA reports


Drug interactions are reported only by a few people who take Methylphenidate hydrochloride and Irbesartan together. This review analyzes the effectiveness and drug interactions between Methylphenidate hydrochloride and Irbesartan. It is created by eHealthMe based on reports of 3 people who take the same drugs from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Feb, 19, 2019

3 people who take Methylphenidate hydrochloride, Irbesartan are studied.


Number of reports submitted per year:

Methylphenidate hydrochloride and Irbesartan drug interactions.

Most common drug interactions over time *:

< 1 month:

n/a

1 - 6 months:
  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Ventricular fibrillation (abnormally irregular heart rhythm)
6 - 12 months:

n/a

1 - 2 years:

n/a

2 - 5 years:

n/a

5 - 10 years:
  1. Anaemia (lack of blood)
  2. Renal failure acute (rapid kidney dysfunction)
10+ years:

n/a

not specified:
  1. Ventricular fibrillation (abnormally irregular heart rhythm)
  2. Anaemia (lack of blood)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  7. Renal failure acute (rapid kidney dysfunction)

Most common drug interactions by gender *:

female:
  1. Anaemia (lack of blood)
  2. Renal failure acute (rapid kidney dysfunction)
male:
  1. Anaemia (lack of blood)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. Ventricular fibrillation (abnormally irregular heart rhythm)

Most common drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:
  1. Anaemia (lack of blood)
  2. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Plasma cell myeloma (cancer that begins in plasma cells)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Ventricular fibrillation (abnormally irregular heart rhythm)

* Approximation only. Some reports may have incomplete information.

Do you take Methylphenidate hydrochloride and Irbesartan?


You are not alone:




Related studies

Methylphenidate hydrochloride

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Methylphenidate hydrochloride 3,131 users)

Irbesartan

Irbesartan has active ingredients of irbesartan. It is often used in high blood pressure. (latest outcomes from Irbesartan 16,059 users)


Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Interactions between Methylphenidate hydrochloride and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Interactions between Irbesartan and drugs from A to Z
a b c d e f g h i j k l m n o p q r s t u v w x y z
Browse all drug interactions of Methylphenidate hydrochloride and Irbesartan
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

What would happen?

Predict new side effects and undetected conditions when you take Methylphenidate hydrochloride and Irbesartan

FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!